sertraline has been researched along with Acute Confusional Senile Dementia in 42 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (9.52) | 18.2507 |
| 2000's | 12 (28.57) | 29.6817 |
| 2010's | 17 (40.48) | 24.3611 |
| 2020's | 9 (21.43) | 2.80 |
| Authors | Studies |
|---|---|
| Khan, JA; Nadeem, MS; Rashid, U | 1 |
| Al-Ghorbani, M; Farooq, U; Jan, MS; Javed, MA; Mannan, A; Rashid, U; Rauf, A; Sadiq, A; Shbeer, AM; Wilairatana, P | 1 |
| Zhang, J; Zhao, Z; Zheng, X | 1 |
| Orgeta, V; Stafford, J; Tuijt, R; Verdaguer, ES | 1 |
| Abe, K; Hishikawa, N; Matsumoto, N; Nomura, E; Ohta, Y; Omote, Y; Sasaki, R; Tadokoro, K; Takemoto, M; Tsunoda, K; Yamashita, T | 1 |
| Li, WH; Liu, XF; Wei, ZW | 1 |
| Avramopoulos, D; Brasic, J; Dannals, RF; Gould, NF; Hall, AW; Holt, DP; Joo, JH; Kraut, M; Kuwabara, H; Mathews, WB; Nandi, A; Nassery, N; Savonenko, A; Smith, GS; Workman, CI | 1 |
| de Cássia Bergamaschi, C; Ferreira, TR; Lopes, LC; Motter, FR | 1 |
| Bai, Y; He, Y; Huang, J; Huang, S; Huang, W; Li, H; Li, Y | 1 |
| Bellomo, A; D'Urso, F; Daniele, A; Dibello, V; Giannelli, G; Greco, A; La Montagna, M; Logroscino, G; Lozupone, M; Panza, F; Piccininni, C; Quaranta, N; Sardone, R; Seripa, D; Solfrizzi, V | 1 |
| Banerjee, S; Chua, KC; Hellier, J; Voshaar, RO; Zuidersma, M | 1 |
| Bies, RR; Drye, LT; Kirshner, M; Li, CH; Lyketsos, CG; Pollock, BG; Sorisio, D; Vaidya, V | 1 |
| Drye, LT; Flynn Longmire, CV; Frangakis, CE; Lyketsos, CG; Martin, BK; Meinert, CL; Mintzer, JE; Munro, CA; Porsteinsson, AP; Rabins, PV; Rosenberg, PB; Schneider, LS; Weintraub, D | 1 |
| Abdollahian, E; Azarpazhooh, A; Haghighi, MB; Mokhber, N; Saghebi, A; Samadi, R; Soltanifar, A | 1 |
| Li, P; Lu, D; Wang, Y; Zhang, HH; Zhou, YY | 1 |
| Chang, YD; Davis, MP; Gutgsell, T; Smith, J | 1 |
| Abernethy, AP; Farrell, TW | 1 |
| Drye, LT; Frangakis, C; Lyketsos, CG; Martin, BK; Meinert, CL; Mintzer, JE; Munro, CA; Porsteinsson, AP; Rabins, PV; Rosenberg, PB; Schneider, LS; Weintraub, D | 2 |
| Mori, N; Suda, S; Sugihara, G; Suyama, R; Takei, N | 1 |
| Drye, LT; Frangakis, CE; Lyketsos, CG; Martin, BK; Meinert, CL; Mintzer, JE; Munro, CA; Porsteinsson, AP; Rabins, PV; Rosenberg, PB; Schneider, LS; Weintraub, D | 1 |
| Frangakis, CE; Lyketsos, CG; Shinohara, RT | 1 |
| Brodaty, H | 1 |
| Baldwin, R; Ballard, C; Banerjee, S; Bentham, P; Burns, A; Dewey, M; Fox, C; Hellier, J; Holmes, C; Katona, C; Knapp, M; Lawton, C; Lindesay, J; Livingston, G; McCrae, N; Moniz-Cook, E; Murray, J; Nurock, S; O'Brien, J; Orrell, M; Poppe, M; Romeo, R; Thomas, A; Walwyn, R; Wilson, K | 1 |
| Avramopoulos, D; Dimitri, A; Drye, LT; Frangakis, CE; Lyketsos, CG; Martin, BK; Meinert, CL; Mintzer, J; Munro, CA; Peters, ME; Porsteinsson, AP; Rabins, PV; Rosenberg, PB; Schneider, LS; Vaidya, V; Weintraub, D | 1 |
| Hsiung, GY; Jacova, C; Lee, PE; Sepehry, AA | 1 |
| Drye, LT; Frangakis, CE; Longmire, CF; Lyketsos, CG; Martin, BK; Meinert, CL; Mintzer, JE; Munro, CA; Porsteinsson, AP; Rabins, PV; Rosenberg, PB; Schneider, LS; Weintraub, D | 1 |
| Eryavec, G; Herrmann, N; Lanctôt, KL; Naranjo, CA; van Reekum, R | 1 |
| Baker, AS; Brandt, J; DelCampo, L; Frangakis, C; Lyketsos, CG; Miles, Q; Munro, C; Rabins, PV; Sheppard, JM; Steele, CD; Steinberg, M | 1 |
| Burt, T; Dysken, M; Finkel, SI; Krishnan, KR; McRae, T; Mintzer, JE | 1 |
| Brandt, J; Lyketsos, CG; Munro, CA; Samus, Q; Steinberg, M; V Rabins, P | 1 |
| Lyketsos, CG; Mielke, MM; Rosenberg, PB | 1 |
| Baker, AS; Bay, RC; Lyketsos, CG; Mayer, LS; Politis, A; Rabins, PV; Steele, C; Steinberg, M | 1 |
| Frangakis, CE; Katz, IR; Lyketsos, CG; Martin, BK; Meinert, CL; Mintzer, JE; Munro, CA; Niederehe, G; Porsteinsson, AP; Rabins, PV; Rosenberg, PB; Schneider, LS | 1 |
| Reynolds, CF | 1 |
| Burke, WJ; Dewan, V; Folks, DG; Nadolny, GC; Roccaforte, WH; Wengel, SP | 1 |
| Cohen, CI; Trappler, B | 1 |
| Cohen, CI; Gomberg, D; Kennedy, G; Magai, C | 1 |
| Volicer, L | 1 |
| Baker, AS; Brandt, J; Kopunek, S; Lyketsos, CG; Rabins, PV; Sheppard, JM; Steele, CD; Steinberg, M | 1 |
| Nace, DA; Towers, AL; Verrico, MM | 1 |
| Muijsers, RB; Noble, S; Plosker, GL | 1 |
9 review(s) available for sertraline and Acute Confusional Senile Dementia
| Article | Year |
|---|---|
A systematic review and meta-analysis on the efficacy outcomes of selective serotonin reuptake inhibitors in depression in Alzheimer's disease.
Topics: Alzheimer Disease; Depression; Escitalopram; Humans; Selective Serotonin Reuptake Inhibitors; Sertraline | 2023 |
Minor and subthreshold depressive disorders in Alzheimer's disease: A systematic review and meta-analysis of prevalence studies.
Topics: Alzheimer Disease; Depression; Depressive Disorder; Humans; Randomized Controlled Trials as Topic; Sertraline | 2020 |
Efficacy of antidepressant drugs in the treatment of depression in Alzheimer disease patients: A systematic review and network meta-analysis.
Topics: Alzheimer Disease; Antidepressive Agents; Cognition; Depression; Humans; Mirtazapine; Network Meta-Analysis; Randomized Controlled Trials as Topic; Sertraline | 2021 |
Pharmacotherapy for the treatment of depression in patients with alzheimer's disease: a treatment-resistant depressive disorder.
Topics: Alzheimer Disease; Antipsychotic Agents; Calcium Channel Blockers; Clinical Trials as Topic; Depressive Disorder, Treatment-Resistant; Humans; Nimodipine; Piperazines; Selective Serotonin Reuptake Inhibitors; Sertraline; Sulfides; Vortioxetine | 2018 |
Pain and palliative care pharmacotherapy literature summaries and analyses.
Topics: Alzheimer Disease; Amphetamines; Anesthetics, Local; Anticoagulants; Antidepressive Agents; Depression; Donepezil; Drug Therapy; Drug-Related Side Effects and Adverse Reactions; Humans; Indans; Lidocaine; Nootropic Agents; Pain; Palliative Care; Phlebotomy; Piperidines; Prescription Drugs; Psychomotor Agitation; Randomized Controlled Trials as Topic; Sertraline; Stevens-Johnson Syndrome; Thromboembolism | 2009 |
Sertraline or mirtazapine for depression in dementia (HTA-SADD): a randomised, multicentre, double-blind, placebo-controlled trial.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Antidepressive Agents; Dementia; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Mental Disorders; Mianserin; Mirtazapine; Randomized Controlled Trials as Topic; Sertraline | 2011 |
Depression: making the diagnosis and using SSRIs in the older patient.
Topics: 1-Naphthylamine; Adult; Aged; Alzheimer Disease; Depressive Disorder; Diagnosis, Differential; Dose-Response Relationship, Drug; Fluoxetine; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline | 1996 |
Tube feeding in Alzheimer's disease is avoidable.
Topics: Alzheimer Disease; Antidepressive Agents; Contraindications; Depression; Dronabinol; Eating; Enteral Nutrition; Humans; Psychotropic Drugs; Sertraline; Weight Loss | 1998 |
Sertraline: a review of its use in the management of major depressive disorder in elderly patients.
Topics: Adolescent; Adult; Age Factors; Aged; Alzheimer Disease; Comorbidity; Depressive Disorder, Major; Humans; MEDLINE; Middle Aged; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline | 2002 |
20 trial(s) available for sertraline and Acute Confusional Senile Dementia
| Article | Year |
|---|---|
The Efficacy of Sertraline, Escitalopram, and Nicergoline in the Treatment of Depression and Apathy in Alzheimer's Disease: The Okayama Depression and Apathy Project (ODAP).
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Antidepressive Agents; Apathy; Citalopram; Depression; Female; Humans; Male; Nicergoline; Nootropic Agents; Prospective Studies; Sertraline; Single-Blind Method; Treatment Outcome | 2020 |
Sertraline and Mirtazapine Versus Placebo in Subgroups of Depression in Dementia: Findings From the HTA-SADD Randomized Controlled Trial.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Antidepressive Agents; Dementia; Depression; Double-Blind Method; England; Female; Humans; Male; Mirtazapine; Sertraline | 2019 |
Population pharmacokinetic modeling of sertraline treatment in patients with Alzheimer disease: the DIADS-2 study.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Antidepressive Agents; Depression; Double-Blind Method; Female; Humans; Male; Middle Aged; Models, Biological; Selective Serotonin Reuptake Inhibitors; Sertraline | 2013 |
Is sertraline treatment or depression remission in depressed Alzheimer patients associated with improved caregiver well being? Depression in Alzheimer's Disease Study 2.
Topics: Aged; Alzheimer Disease; Caregivers; Cost of Illness; Depression; Double-Blind Method; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Quality of Life; Remission, Spontaneous; Sertraline; Stress, Psychological | 2014 |
Comparison of sertraline, venlafaxine and desipramine effects on depression, cognition and the daily living activities in Alzheimer patients.
Topics: Activities of Daily Living; Aged; Alzheimer Disease; Antidepressive Agents; Cognition; Comorbidity; Depressive Disorder, Major; Desipramine; Double-Blind Method; Female; Humans; Male; Middle Aged; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride | 2014 |
Sertraline for the treatment of depression in Alzheimer disease.
Topics: Aged; Alzheimer Disease; Depression; Double-Blind Method; Female; Humans; Male; Medication Adherence; Patient Dropouts; Placebos; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 2010 |
Sertraline for the treatment of depression in Alzheimer disease: week-24 outcomes.
Topics: Activities of Daily Living; Aged; Alzheimer Disease; Antidepressive Agents; Cognition Disorders; Depression; Female; Geriatric Assessment; Humans; Male; Mental Disorders; Patient Compliance; Quality of Life; Sertraline | 2010 |
Do treatment effects vary among differing baseline depression criteria in depression in Alzheimer's disease study ± 2 (DIADS-2)?
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Antidepressive Agents; Depressive Disorder; Female; Humans; Male; Outcome Assessment, Health Care; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline | 2011 |
Sertraline or mirtazapine for depression in dementia (HTA-SADD): a randomised, multicentre, double-blind, placebo-controlled trial.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Antidepressive Agents; Dementia; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Mental Disorders; Mianserin; Mirtazapine; Randomized Controlled Trials as Topic; Sertraline | 2011 |
Cognitive outcomes after sertaline treatment in patients with depression of Alzheimer disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Ambulatory Care Facilities; Antidepressive Agents; Cognition; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Neuropsychological Tests; Sertraline; Treatment Outcome | 2012 |
Gender, aggression and serotonergic function are associated with response to sertraline for behavioral disturbances in Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Aggression; Alzheimer Disease; Cross-Over Studies; Double-Blind Method; Female; Humans; Male; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Sertraline; Sex Factors; Treatment Outcome | 2002 |
Treating depression in Alzheimer disease: efficacy and safety of sertraline therapy, and the benefits of depression reduction: the DIADS.
Topics: Activities of Daily Living; Aged; Alzheimer Disease; Ambulatory Care; Caregivers; Cognition Disorders; Comorbidity; Depressive Disorder; Drug Administration Schedule; Female; Geriatric Assessment; Humans; Male; Mental Disorders; Neuropsychological Tests; Placebos; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Single-Blind Method; Treatment Outcome | 2003 |
A randomized, placebo-controlled study of the efficacy and safety of sertraline in the treatment of the behavioral manifestations of Alzheimer's disease in outpatients treated with donepezil.
Topics: Aged; Alzheimer Disease; Ambulatory Care; Antidepressive Agents; Behavioral Symptoms; Cholinesterase Inhibitors; Donepezil; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Indans; Male; Middle Aged; Neuropsychological Tests; Nootropic Agents; Piperidines; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 2004 |
Patient predictors of response to treatment of depression in Alzheimer's disease: the DIADS study.
Topics: Aged; Aggression; Alzheimer Disease; Antidepressive Agents; Caregivers; Depressive Disorder, Major; Female; Geriatric Assessment; Humans; Male; Neuropsychological Tests; Psychiatric Status Rating Scales; Psychomotor Agitation; Sertraline; Single-Blind Method; Treatment Outcome | 2004 |
Caregiver assessment of patients' depression in Alzheimer disease: longitudinal analysis in a drug treatment study.
Topics: Affect; Aged; Alzheimer Disease; Antidepressive Agents; Bias; Caregivers; Comorbidity; Cost of Illness; Depressive Disorder, Major; Double-Blind Method; Humans; Longitudinal Studies; Outcome Assessment, Health Care; Personality Assessment; Psychometrics; Reproducibility of Results; Sertraline | 2005 |
Comparison of three rating scales as outcome measures for treatment trials of depression in Alzheimer disease: findings from DIADS.
Topics: Aged; Alzheimer Disease; Comorbidity; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Placebos; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Statistics as Topic; Treatment Outcome | 2006 |
Design of Depression in Alzheimer's Disease Study-2.
Topics: Affect; Aged; Alzheimer Disease; Antidepressive Agents, Second-Generation; Caregivers; Combined Modality Therapy; Cost of Illness; Counseling; Depressive Disorder; Female; Follow-Up Studies; Humans; Male; Patient Dropouts; Problem Solving; Quality Assurance, Health Care; Research Design; Selective Serotonin Reuptake Inhibitors; Sertraline; Social Support; Treatment Outcome | 2006 |
Use of SSRIs in "very old" depressed nursing home residents.
Topics: 1-Naphthylamine; Aged; Aged, 80 and over; Alzheimer Disease; Central Nervous System Diseases; Dementia, Vascular; Depressive Disorder; Female; Fluoxetine; Homes for the Aged; Humans; Male; Matched-Pair Analysis; New York; Nursing Homes; Paroxetine; Prospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline; Statistics, Nonparametric | 1998 |
A controlled clinical trial of sertraline in the treatment of depression in nursing home patients with late-stage Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Antidepressive Agents; Cognition Disorders; Depressive Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Neuropsychological Tests; Nursing Homes; Sertraline; Severity of Illness Index | 2000 |
Randomized, placebo-controlled, double-blind clinical trial of sertraline in the treatment of depression complicating Alzheimer's disease: initial results from the Depression in Alzheimer's Disease study.
Topics: Aged; Alzheimer Disease; Ambulatory Care; Comorbidity; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Placebos; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 2000 |
14 other study(ies) available for sertraline and Acute Confusional Senile Dementia
| Article | Year |
|---|---|
Fluoxetine and sertraline based multitarget inhibitors of cholinesterases and monoamine oxidase-A/B for the treatment of Alzheimer's disease: Synthesis, pharmacology and molecular modeling studies.
Topics: Alzheimer Disease; Animals; Cholinesterase Inhibitors; Drug Design; Fluoxetine; Humans; Mice; Monoamine Oxidase Inhibitors; Sertraline; Structure-Activity Relationship | 2021 |
Evaluation of pyrimidine/pyrrolidine-sertraline based hybrids as multitarget anti-Alzheimer agents: In-vitro, in-vivo, and computational studies.
Topics: Acetylcholinesterase; Alzheimer Disease; Cholinesterase Inhibitors; Humans; Molecular Docking Simulation; Pyrimidines; Sertraline; Structure-Activity Relationship | 2023 |
Clinical efficacy of sertraline in the treatment of depression caused by Alzheimer disease: A protocol of systematic review.
Topics: Alzheimer Disease; Antidepressive Agents; Depression; Humans; Randomized Controlled Trials as Topic; Research Design; Sertraline; Systematic Reviews as Topic; Treatment Outcome | 2020 |
Molecular imaging of beta-amyloid deposition in late-life depression.
Topics: Age Factors; Aged; Alzheimer Disease; Amyloid beta-Peptides; Antidepressive Agents, Second-Generation; Citalopram; Dementia; Depression; Female; Gray Matter; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Molecular Imaging; Positron-Emission Tomography; Sertraline | 2021 |
Potentially inappropriate prescriptions to Brazilian older people with Alzheimer disease: A cross-sectional study.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Aspirin; Brazil; Cardiovascular Agents; Central Nervous System Agents; Clonazepam; Cross-Sectional Studies; Drug Interactions; Female; Humans; Inappropriate Prescribing; Male; Polypharmacy; Quetiapine Fumarate; Sertraline | 2021 |
Correlated patterns of neuropsychological and behavioral symptoms in frontal variant of Alzheimer disease and behavioral variant frontotemporal dementia: a comparative case study.
Topics: Aged; Alzheimer Disease; Behavioral Symptoms; Cognition Disorders; Female; Follow-Up Studies; Frontal Lobe; Frontotemporal Dementia; Humans; Middle Aged; Neuroimaging; Neuropsychological Tests; Selective Serotonin Reuptake Inhibitors; Sertraline | 2016 |
Pseudobulbar Affect or Depression in Dementia?
Topics: Aged, 80 and over; Alzheimer Disease; Crying; Depression; Diagnosis, Differential; Female; Humans; Selective Serotonin Reuptake Inhibitors; Sertraline | 2016 |
Donepezil and concurrent sertraline treatment is associated with increased hippocampal volume in a patient with depression.
Topics: Adult; Alzheimer Disease; Atrophy; Cholinesterase Inhibitors; Cognition Disorders; Depressive Disorder, Major; Diagnosis, Differential; Donepezil; Drug Therapy, Combination; Female; Follow-Up Studies; Functional Laterality; Hippocampus; Humans; Indans; Magnetic Resonance Imaging; Piperidines; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 2010 |
A broad symmetry criterion for nonparametric validity of parametrically based tests in randomized trials.
Topics: Alzheimer Disease; Antidepressive Agents; Data Interpretation, Statistical; Humans; Outcome Assessment, Health Care; Randomized Controlled Trials as Topic; Sertraline; Statistics, Nonparametric; Treatment Outcome; Validation Studies as Topic | 2012 |
Antidepressant treatment in Alzheimer's disease.
Topics: Aged, 80 and over; Alzheimer Disease; Antidepressive Agents; Dementia; Depressive Disorder; Double-Blind Method; Humans; Mianserin; Mirtazapine; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Sertraline | 2011 |
Sertraline for the treatment of depression in Alzheimer disease: genetic influences.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Depression; Female; Genotype; Humans; Male; Middle Aged; Multicenter Studies as Topic; Polymorphism, Genetic; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 2011 |
Stay the course--is it justified?
Topics: Alzheimer Disease; Antidepressive Agents; Dementia; Depressive Disorder; Female; Humans; Male; Mental Disorders; Mianserin; Sertraline | 2012 |
The use of selective serotonin reuptake inhibitors for depression and psychosis complicating dementia.
Topics: 1-Naphthylamine; Aged; Aged, 80 and over; Alzheimer Disease; Dementia; Depressive Disorder; Female; Humans; Male; Paroxetine; Psychotic Disorders; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline | 1997 |
Fulminant chemical hepatitis possibly associated with donepezil and sertraline therapy.
Topics: Aged; Aged, 80 and over; Alkaline Phosphatase; Alzheimer Disease; Bilirubin; Biopsy; Chemical and Drug Induced Liver Injury; Cholestasis; Donepezil; Drug Monitoring; Drug Therapy, Combination; Female; gamma-Glutamyltransferase; Humans; Indans; Liver Failure, Acute; Liver Function Tests; Nootropic Agents; Piperidines; Selective Serotonin Reuptake Inhibitors; Sertraline; Tomography, X-Ray Computed | 2000 |